DTIL

Precision BioSciences, Inc.

Sağlık

NON-COMPLIANT — One or more ratios exceed the threshold; the company is not compliant with halal investment criteria.

$8.04

Price (1 Year)

$10.6 $3.79

Participation Finance Screening Ratios

Non-compliant debt / Total market cap %25.7 / %30
Non-compliant assets / Total market cap %18 / %30
Non-compliant revenue / Total income %20.7 / %5

Ratios are taken from an AAOIFI-based screening file; this does not constitute a religious ruling.

About the Company

Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair.

Website

Analysis (Turkish): DTIL Hissesi Caiz mi, Helal mi? Precision BioSciences, Inc. Katılım Analizi